Development and initial validation of a Traditional Chinese Medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ)
- PMID: 24359229
- PMCID: PMC3881015
- DOI: 10.1186/1477-7525-11-212
Development and initial validation of a Traditional Chinese Medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ)
Abstract
Background: Zheng represents pattern differentiation in Traditional Chinese Medicine (TCM), as the basic unit and a key concept in TCM therapeutic theory, is based on the physiology and pathology of TCM. None of the outcome measurements of atopic dermatitis (AD) are Zheng-specific. The effectiveness of TCM is likely to be underestimated without a Zheng-related symptom-specific instrument. The aim of this study was to develop an instrument for measuring the Zheng-related symptom-specific status of patients with AD.
Methods: We followed standard methodology to develop the instrument, including item generation and selection, item reduction and presentation, and pretesting, and recruited 188 patients with AD involved in a six-center randomized-controlled trial (ChiCTR-TRC-08000156) to validate the questionnaire. We conducted construct validity, reliability, and responsiveness analysis. The standardized effect size (SES) and standardized response mean (SRM) were used to calculate the responsiveness of additional items and the total score for the rating items.
Results: ZRADSQ has 15 items, with 12 rating items and 3 additional items. The 12 rating items fall within three domains: AD symptoms (n = 6 items); Heat (n = 4 items) and Mood (n = 2 items). Confirmatory factor analysis provided good support for a three-factor model (d.f. = 51, x2=97.11, RMSEA = 0.07, CFI = 0.96), and the Pearson's correlation coefficient between ZRADSQ and Severity Scoring of Atopic Dermatitis (SCORAD) was 0.40 (P < 0.001). The reliability was also good, with a Cronbach's alpha value for ZRADSQ of 0.84, a split-half coefficient of 0.75, and a test-retest reliability coefficient of 0.98. The standardized effect size and standardized response mean were close to or larger than 1, which indicated moderate to good responsiveness.
Conclusions: The ZRADSQ demonstrates promising reliability, validity, and responsiveness. It can be used to determine whether Zheng-specific or symptom-specific treatments relieve the symptom that is most bothersome the patient.
Figures
Similar articles
-
A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).Br J Dermatol. 2004 Feb;150(2):274-83. doi: 10.1111/j.1365-2133.2004.05783.x. Br J Dermatol. 2004. PMID: 14996098
-
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT).Curr Med Res Opin. 2020 Mar;36(3):367-376. doi: 10.1080/03007995.2019.1699516. Epub 2019 Dec 12. Curr Med Res Opin. 2020. PMID: 31778083
-
Development and validation of a questionnaire to measure empowerment in adult patients with atopic dermatitis. The DATEMP questionnaire.J Dtsch Dermatol Ges. 2019 Sep;17(9):923-931. doi: 10.1111/ddg.13934. Epub 2019 Sep 5. J Dtsch Dermatol Ges. 2019. PMID: 31487109
-
[A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine].Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):726-37. doi: 10.3736/jcim20120702. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 22805078 Review. Chinese.
-
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS).Curr Med Res Opin. 2019 Jul;35(7):1139-1148. doi: 10.1080/03007995.2018.1560222. Epub 2019 Jan 17. Curr Med Res Opin. 2019. PMID: 30561230 Review.
Cited by
-
Evaluating traditional Chinese medicine diagnostic instruments for functional dyspepsia: systematic review on measurement properties.Integr Med Res. 2021 Sep;10(3):100713. doi: 10.1016/j.imr.2020.100713. Epub 2020 Dec 24. Integr Med Res. 2021. PMID: 33665098 Free PMC article. Review.
-
Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.Ann Transl Med. 2022 Aug;10(16):906. doi: 10.21037/atm-22-3164. Ann Transl Med. 2022. PMID: 36111032 Free PMC article. Review.
-
Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC/Nga mice by regulation of PKC and IL-4.BMC Complement Altern Med. 2016 Oct 24;16(1):416. doi: 10.1186/s12906-016-1394-4. BMC Complement Altern Med. 2016. PMID: 27776525 Free PMC article.
-
Synergistic effect of Mahaenggamseok-tang in the treatment of pediatric patients with lower respiratory tract infections: A PRISMA-compliant systematic review and meta-analysis.Medicine (Baltimore). 2022 Mar 18;101(11):e28931. doi: 10.1097/MD.0000000000028931. Medicine (Baltimore). 2022. PMID: 35356901 Free PMC article.
-
Efficacy of Traditional Herbal Medicine Treatment Based on Pattern Identification for Idiopathic Parkinson's Disease: A Protocol for Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2022 Apr 30;2022:4777849. doi: 10.1155/2022/4777849. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35535156 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous